Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +45.25%
#2 Mubarak Mubarak +41.77%
#3 Pons Pons +38.98%
#4 Bitway Bitway +33.87%
#5 TENDIES TENDIES +30.00%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.88%
#7 Starpower Starpower +28.91%
#8 SkyAI SkyAI +24.04%
#9 Ocean Protocol Ocean Protocol +20.97%
#10 Decred Decred +20.59%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Human Metabolome Technologies, Inc. Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc.

6090
Rangering i aksjer #29373
Human Metabolome Technologies, Inc. is a biotechnology company based in... Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
Aksjekurs
$3.86
Markedsverdi
$21.49M
Endring (1 dag)
-0.17%
Endring (1 år)
-25.27%
Land
JP
Handel Human Metabolome Technologies, Inc. (6090)

Kategori

Healthcare
Inntekter for Human Metabolome Technologies, Inc. (6090)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Human Metabolome Technologies, Inc. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Human Metabolome Technologies, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH